HeartBeam (BEAT) Earnings Analysis
HeartBeam (BEAT) next reports earnings on 2026-08-12, consensus EPS -0.1 USD. Last quarter (2026-03-12) it missed with EPS -0.14 USD vs -0.13 USD est (-7.7%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -0.98.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BEAT next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.1 USD |
| Revenue estimate | 0.00B |
BEAT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -0.14 USD | -0.13 USD | -7.7% | Miss |
| 2025-11-13 | -0.15 USD | -0.16 USD | +6.3% | Beat |
| 2025-08-13 | -0.15 USD | -0.16 USD | +6.3% | Beat |
| 2025-03-13 | -0.18 USD | -0.19 USD | +5.3% | Beat |
| 2024-11-07 | -0.19 USD | -0.17 USD | -11.8% | Miss |
| 2024-08-14 | -0.19 USD | -0.16 USD | -18.8% | Miss |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
BEAT valuation and analyst view
| Trailing P/E | -0.98 |
|---|---|
| Trailing EPS | -0.49844 USD |
| Price / book | 35.58 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (9 buy / 4 hold / 0 sell) |
| Avg price target | 2 USD |
Related research pages
Frequently asked questions
When is HeartBeam (BEAT)'s next earnings date?
HeartBeam is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.1 USD and revenue estimate of 0.00B.
Did BEAT beat earnings last quarter?
In its 2026-03-12 report, BEAT posted EPS of -0.14 USD versus a -0.13 USD estimate — a miss of 7.7%.
What is BEAT's earnings track record?
Over the last 6 reported quarters with consensus data, BEAT beat estimates 3 times (50%).
What is BEAT's current P/E ratio and EPS?
BEAT trades at a trailing P/E of -0.98 on trailing EPS of -0.4984430890758526 USD.
What do analysts rate BEAT?
Analyst consensus is "Buy" across 13 ratings (0 strong buy, 9 buy, 4 hold, 0 sell, 0 strong sell). Average 12-month price target: 2 USD.